Safety and Efficacy Study of Albiglutide in Type 2 Diabetes

Completed · Phase 3 · Has a placebo group

Conditions studied: Diabetes Mellitus, Type 2

In brief

The purpose of this study is to determine whether albiglutide is effective in the treament of patients with type 2 diabetes.

Key facts

Study ID

NCT00849017

Run by

GlaxoSmithKline

People needed

309

Starts

2009-01-01

Expected to finish

2013-02-01

Last updated by the study team

2017-01-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• type 2 diabetes
• BMI 20-45kg/m2 inclusive

You may not qualify if…

• females who are pregnant, lactating, or <6 weeks post-partum
• CHF NYHA class III-IV

Where it is running

• GSK Investigational Site — Birmingham, Alabama, United States
• GSK Investigational Site — Birmingham, Alabama, United States
• GSK Investigational Site — Dothan, Alabama, United States
• GSK Investigational Site — Chandler, Arizona, United States
• GSK Investigational Site — Gilbert, Arizona, United States
• GSK Investigational Site — Green Valley, Arizona, United States
• GSK Investigational Site — Phoenix, Arizona, United States
• GSK Investigational Site — Tucson, Arizona, United States
• GSK Investigational Site — Bull Shoals, Arkansas, United States
• GSK Investigational Site — Hot Springs, Arkansas, United States
• GSK Investigational Site — Jonesboro, Arkansas, United States
• GSK Investigational Site — Little Rock, Arkansas, United States
• GSK Investigational Site — Searcy, Arkansas, United States
• GSK Investigational Site — Carmichael, California, United States
• GSK Investigational Site — Chula Vista, California, United States
• GSK Investigational Site — Foothill Ranch, California, United States
• GSK Investigational Site — Fresno, California, United States
• GSK Investigational Site — Huntington Beach, California, United States
• GSK Investigational Site — Huntington Beach, California, United States
• GSK Investigational Site — Indio, California, United States
• GSK Investigational Site — Irvine, California, United States
• GSK Investigational Site — Lakewood, California, United States
• GSK Investigational Site — Long Beach, California, United States
• GSK Investigational Site — Los Alamitos, California, United States
• GSK Investigational Site — Alabaster, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.